Tuesday, May 8, 2012 - 01:20 in Health & Medicine
As an advisory panel prepared to consider whether to recommend federal approval of Pfizer’s rheumatoid arthritis pill, F.D.A. documents raise safety questions.
- Wide variability in rheumatoid arthritis drug suggests alternative dosing should be consideredTue, 4 Nov 2008, 13:35:52 EST
- Rheumatoid arthritis breakthroughTue, 11 Nov 2008, 20:22:03 EST
- Novel drugs selectively target pathway important in rheumatoid arthritisTue, 13 Jan 2009, 16:57:27 EST
- New biologic drug is effective against rheumatoid arthritisTue, 6 Oct 2009, 19:52:33 EDT
- Rheumatoid arthritis: Worse in women?Tue, 13 Jan 2009, 19:36:18 EST